CoChat

A Multicenter Evaluation of a Point-of-Care Blood Glucose Meter System in Critically Ill Patients

Open access

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Background: Our purpose was to evaluate the performance of the ACCU-CHEK® Inform II blood glucose monitoring system (Roche Diagnostics GmbH) compared with the perchloric acid hexokinase (PCA-HK) comparator method on the cobas® 6000 analyzer (Roche Diagnostics International Ltd) in critically ill patients. Methods: Overall, 476 arterial (376 pediatric/adult, 100 neonate), 375 venous, and 100 neonatal heel-stick whole-blood samples were collected and evaluated from critical care settings at 10 US hospitals, including the emergency department, medical and surgical intensive care units (ICUs), and neonatal and pediatric ICUs. The ACCU-CHEK Inform II system was evaluated at 2 cutoff boundaries: boundary 1 was ≥95% of results within ±12 mg/dL of the reference (samples with blood glucose <75 mg/dL) or ±12% of the reference (glucose ≥75 mg/dL), and boundary 2 was ≥98% of results within ±15 mg/dL or ±15% of the reference. Clinical performance was assessed by evaluating sample data using Parkes error grid, Monte Carlo simulation, and sensitivity and specificity analyses to estimate clinical accuracy and implications for insulin dosing when using the ACCU-CHEK Inform II system. Results: Proportions of results within evaluation boundaries 1 and 2, respectively, were 96% and 98% for venous samples, 94% and 97% for pediatric and adult arterial samples, 84% and 98% for neonatal arterial samples, and 96% and 100% for neonatal heel-stick samples. Clinical evaluation demonstrated high specificity and sensitivity, with low risk of potential insulin-dosing errors. Conclusions: The ACCU-CHEK Inform II system demonstrated clinically acceptable performance against the PCA-HK reference method for blood glucose monitoring in a diverse population of critically ill patients in US care settings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jalm/jfab005

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 . Fig.1. Parkes error grid for the ACCU-CHEK Inform II system (pediatric/adult arterial and venous samples, n 5 750; 750 of 751 samples qualified for analysis). The error grid specifies 5 zones corresponding to different levels of risk, from none (A) to dangerous (E)(24). Analyses performed on the paired ACCU-CHEK system or PCA-HK positioned all results within these zones. The triangle denotes results outside the safest zone (A). One sample with glucose concentration (comparator measurement) of 563.64 mg/dL was excluded because it exceeds the maximum permissible for inclusion (550 mg/dL).
Fig. 1 . Fig.1. Parkes error grid for the ACCU-CHEK Inform II system (pediatric/adult arterial and venous samples, n 5 750; 750 of 751 samples qualified for analysis). The error grid specifies 5 zones corresponding to different levels of risk, from none (A) to dangerous (E)(24). Analyses performed on the paired ACCU-CHEK system or PCA-HK positioned all results within these zones. The triangle denotes results outside the safest zone (A). One sample with glucose concentration (comparator measurement) of 563.64 mg/dL was excluded because it exceeds the maximum permissible for inclusion (550 mg/dL).CC-BY · From the PDF
Fig. 2 . Fig. 2. Monte Carlo simulation modeling: contour plot of insulin-dosing error rates of !2 dosing error categories created using simulation. True bias estimates are plotted at CV 5 3.25% and jittered in x-direction to disperse vertical aggregation and make individual points visible. The %bias and %CV of points within the contour bands are likely to generate !2 dosing errors (0.05%-20%).
Fig. 2 . Fig. 2. Monte Carlo simulation modeling: contour plot of insulin-dosing error rates of !2 dosing error categories created using simulation. True bias estimates are plotted at CV 5 3.25% and jittered in x-direction to disperse vertical aggregation and make individual points visible. The %bias and %CV of points within the contour bands are likely to generate !2 dosing errors (0.05%-20%).CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Li, 2017, Glucose monitoring and management in the NICU—how are we doing?, Infant, 13, 182

Cited by

See all 19

Metadata

Authors
Nichols, J. H., Brandler, E. S., Fantz, C. R., Fisher, K., Goodman, M. D., Headden, G., Hoppensteadt, D., Matika, R., Peacock, W. F., Rodrigo, J., Schützenmeister, A., Swanson, J. R., Canada-Vilalta, C., Miles, G., & Tran, N.
Affiliations
  • Vanderbilt University (US)
  • Stony Brook University Hospital (US)
  • Roche (United States) (US)
  • Duke Medical Center (US)
  • University of Cincinnati Medical Center (US)
  • Medical University of South Carolina (US)
  • Loyola University Medical Center (US)
  • Banner - University Medical Center Tucson (US)
  • Ben Taub Hospital (US)
  • UC Davis Health (US)
  • Roche Diagnostics GmbH, Penzberg, Germany
  • University of Virginia Children's Hospital (US)
  • Roche Diagnostics Corporation, Clinical Operations, Indianapolis, IN, USA
Corresponding author
Tran, Nam
Venue
The Journal of Applied Laboratory Medicine
Published
2021-06-05
Volume
6
Issue
4
Pages
820-833
ISSN
  • 2475-7241 (ISSN-L)
  • 2576-9456
OpenAlex
W3146691987
Cited by
19
References
21
Citations by year
2026: 3 · 2025: 5 · 2023: 7 · 2022: 1 · 2021: 3
FWCI
2.05
Type
journal article
Language
en
Open access
Locations
  • The Journal of Applied Laboratory Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Roche Diagnostics International Ltd
  • Rotkreuz
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
critically ill patients, blood glucose monitoring, arterial blood glucose, venous blood glucose, pediatric intensive care, intensive care unit, insulin dosing errors, diagnostic accuracy, Monte Carlo simulation
MeSH terms
Adult, Blood Glucose, Child, Critical Care, Humans, Infant, Newborn, Blood Glucose Self-Monitoring, Critical Illness, Point-of-Care Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.